Results 161 to 170 of about 4,708 (180)
Some of the next articles are maybe not open access.
Audiologic Threshold Monitoring of Patients Receiving Ototoxic Drugs
Annals of Otology, Rhinology & Laryngology, 1989An effort was made to determine the efficacy of auditory threshold monitoring of patients receiving ototoxic drugs. Forty-four patients treated with either tobramycin or vancomycin for osteomyelitis were tested at the beginning of treatment, following treatment, and twice weekly during treatment when possible.
W L, Meyerhoff +3 more
openaire +2 more sources
[Monitoring drug ototoxicity with distortion products].
Acta otorrinolaringologica espanola, 2000Distortion products are currently considered an objective method for rapidly evaluating the functional status of the cochlea, which is interesting for the monitoring of drug ototoxicity. We studied 40 ears from patients who had received an ototoxic drug, tobramycin.
M, Orts Alborch +5 more
openaire +1 more source
High-Frequency Audiometric Monitoring Strategies for Early Detection of Ototoxicity
Ear and Hearing, 1994Therapeutic drugs such as the aminoglycoside antibiotics (AMG) and the chemotherapy agent cisplatin (CDDP) are known to cause irreversible hearing loss, typically affecting highest frequency hearing first with progression of loss to the lower frequency regions.
Fausti, Stephen A. +5 more
openaire +3 more sources
Gentamicin-induced ototoxicity in a carefully monitored renal-failure patient
American Journal of Health-System Pharmacy, 1981A case of gentamicin-induced ototoxicity, documented by electronystagmography and audiometry, in a patient with chronic renal failure is presented. A 39-year-old white man was hospitalized for a renal transplant procedure. Multiple postoperative complications included infection, and the transplanted kidney was rejected eventually.
openaire +2 more sources
[Monitoring hearing during ototoxic cisplatin therapy].
Padiatrie und Grenzgebiete, 1990In the 1983-1988 period, the audition of 17 children was studied prior to and during antineoplastic chemotherapy with cumulative total cisplatin doses from 270 to 1530 mg/m2. The hearing tests were conducted by means of an objective method which doses not depend on patients' cooperation: the recording of fast auditory evoked potentials.
J, Kluba +3 more
openaire +1 more source
The current state of ototoxicity monitoring in New Zealand.
The New Zealand medical journal, 2014To explore medical oncologists' and audiologists' knowledge and attitudes regarding ototoxicity monitoring, and to gain an understanding of monitoring currently being implemented at District Health Boards (DHBs) nationwide. We also aimed to identify ways in which audiological outcomes for patients receiving potentially ototoxic treatments could be ...
Lotte, Steffens +5 more
openaire +1 more source
Otoacoustic emissions analysers for monitoring aminoglycosides ototoxicity.
Romanian journal of internal medicine = Revue roumaine de medecine interne, 2010Aminoglycosides (AG) are widely prescribed despite their notorious toxicity. These antibiotics cause irreversible hearing loss, starting with high frequencies and progressing toward conversational frequencies (0.5-2 kHz), by destroying the acoustic hair cells in the inner ear.
Ruxandra Moroti, Constantinescu +7 more
openaire +1 more source
Bedside High Frequency Monitoring for Ototoxicity
Otolaryngology–Head and Neck Surgery, 1997B SINKS, J GOEBEL
openaire +1 more source
Audiologic identification and monitoring of ototoxicity
Current Opinion in Otolaryngology & Head and Neck Surgery, 1994Terry L. Wiley, Daniel T. Stoppenbach
openaire +1 more source
A Need for Ototoxicity Monitoring in Adults with Rheumatoid Arthritis
The Hearing Journal, 2022Katijah Khoza-Shangase, Rebecca-Ann Riva
openaire +1 more source